Lanean...
HER2-targeted therapy influences CTC status in metastatic breast cancer
PURPOSE: As an independent, negative-prognostic biomarker for progression-free survival (PFS) and overall survival (OS), circulating tumor cells (CTCs) constitute a promising component for developing a liquid biopsy for patients with metastatic breast cancer (MBC). The effects of HER2-targeted thera...
Gorde:
| Argitaratua izan da: | Breast Cancer Res Treat |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer US
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7274999/ https://ncbi.nlm.nih.gov/pubmed/32436146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05687-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|